EU imposes €200m fine on Temu over safety breaches
The European Commission has levied a significant penalty against Temu for failing to safeguard consumers from toxic and unsafe goods, a move the retailer has formally contested.

The European Union has imposed a €200 million fine on Chinese e-commerce retailer Temu for facilitating the sale of products deemed toxic or unsafe. The penalty specifically cites the distribution of hazardous items, including baby toys and electronics, marking a significant escalation in regulatory oversight of cross-border digital marketplaces.
The enforcement action was issued under the Digital Services Act (DSA), a comprehensive framework designed to hold online platforms accountable for the content and goods available on their services. Under this legislation, major platforms are mandated to implement robust mechanisms to protect consumers from harmful products, with non-compliance attracting substantial financial penalties.
Temu has formally disputed the ruling, challenging the European Union’s determination regarding the safety standards of its inventory. While the specific legal arguments underpinning the retailer’s opposition are not detailed in the initial announcement, the dispute highlights the ongoing tension between rapid e-commerce expansion and stringent consumer protection mandates within the single market.
The fine underscores the European Commission’s commitment to enforcing the Digital Services Act against major global technology and retail entities. By targeting high-volume platforms, regulators are signalling that the obligation to vet product safety applies equally to domestic and international operators operating within EU jurisdiction.
This incident represents a critical test case for the practical application of digital regulation in the e-commerce sector. As the EU continues to refine its approach to platform governance, the outcome of Temu’s challenge will likely influence how other international retailers structure their compliance and safety protocols to avoid similar regulatory scrutiny.


